Simplexia
Simplexia is develops vaccine against herpes simplex virus type (HSV-2) infection, which is the most common sexually transmitted infection in the world. The infection causes genital herpes with painful and recurrent genital blisters. HSV-2 can also cause life-threatening encephalitis and meningitis in newborns and immunocompromised patients. A major issue is that HSV-2 infected patients also suffer a three-fold increased risk of HIV acquisition.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Simplexia
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- LD
Lena Degling Wikingsson
Chairman of the Board of Directors · General Business & Management
EmailPhone - TW
Tim Wood
Chief Executive Officer · General Business & Management
EmailPhone
Showing 2 of 4 verified contacts
Top roles at Simplexia
2 distinct titles indexed · top 2 shown.
- 1chairman of the board of directors
- 1chief executive officer
Sign up to unlock all 4 contacts at Simplexia
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Simplexia
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.